Hypercoagulability in COVID-19: from an unknown beginning to future therapies
Sign Up to like & getrecommendations! Published in 2022 at "Medicine and Pharmacy Reports"
DOI: 10.15386/mpr-2195
Abstract: Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global public health concern and is characterized by an exaggerated inflammatory response that can lead to a large variety… read more here.
Keywords: hypercoagulability covid; beginning future; unknown beginning; risk ... See more keywords